Progression to bacteremia in critical care patients colonized with methicillin-resistant Staphylococcus aureus expressing Panton-Valentine leukocidin

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 1, 2010, Pages 28-33

  Blaine, Kevin P ^a   Tuohy, Marion J ^b   Wilson, Deborah ^b   Procop, Gary W ^b   Tisch, Daniel J ^c   Shrestha, Nabin K ^b   Hall, Geraldine S ^b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Bacteremia; ICU infections; Methicillin resistant Staphylococcus aureus; Nasal colonization; Panton Valentine leukocidin

Indexed keywords

CEFOXITIN; METICILLIN; PANTON VALENTINE LEUKOCIDIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING;

EID: 77955830646     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.04.013     Document Type: Article

References (42)

1. Balis E., Diacaki C., Tselioti P., Perimeni D., Vourli S., Vatopoulos A., Giamarellou H., Prekates A. Community-acquired pneumonia and bacteremia due to methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin gene in Greece: two case reports and literature review. J. Chemother. 2007, 19:703-708.
2. Boyle-Vavra S., Daum R. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab. Invest. 2007, 87:3-9.
3. Boyle-Vavra S., Ereshefsky B., Wang C.C., Daum R.S. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J. Clin. Microbiol. 2005, 43:4719-4730.
4. Chini V., Petinaki E., Meugnier H., Foka A., Bes M., Etienne J., Dimitracopoulos G., Spiliopoulou I. Emergence of a new clone carrying Panton-Valentine leukocidin genes and staphylococcal cassette chromosome mec type V among methicillin-resistant Staphylococcus aureus in Greece. Scand. J. Infect. Dis. 2008, 40:368-372.
5. Coates T., Bax R., Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J. Antimicrob. Chemother. 2009, 64:9-15.
6. Datta R., Huang S. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin. Infect. Dis. 2008, 2008:2.
7. Davis S., Perri M., Donabedian S.M., Manierski C., Singh A., Vager D., Haque N.Z., Speirs K., Muder R.R., Robinson-Dunn B., Hayden M.K., Zervos M.J. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J. Clin. Microbiol. 2007, 45:1705-1711.
8. Diep B., Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol. 2008, 16:361-369.
9. Diep B., Palazzolo-Ballance A., Tattevin P., Basuino L., Braughton K.R., Whitney A.R., Chen L., Kreiswirth B.N., Otto M., DeLeo F.R., Chambers H.F. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 2008, 3:e3198.
10. Dohin B., Gillet Y., Kohler R., Lina G., Vandenesch F., Vanhems P., Floret D., Etienne J. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr. Infect. Dis. J. 2007, 26:1042-1048.
11. Ellington M., Hope R., Ganner M., Ganner M., East C., Brick G., Kearns A.M. Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK?. J. Antimicrob. Chemother. 2007, 60:402-405.
12. Entenza J., Que Y., Vouillamoz J., Glauser M.P., Moreillon P. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob. Agents Chemother. 2001, 45:3076-3083.
13. Ganesan A. Methicillin-resistant Staphylococcus aureus bacteremia and pneumonia. Dis. Mon. 2008, 54:787-792.
14. Gilpin D.F., Small S., Bakkshi S., Kearney M.P., Cardwell C., Tunney M.M. Efficacy of a standard methicillin-resistant Staphylococcus aureus decolonisation protocol in routine clinical practice. J. Hosp. Infect. 2010, 75:93-98.
15. Hansen S., Schwab F., Asensio A., Carsauw H., Heczko P., Klavs I., Lyytikäinen O., Palomar M., Riesenfeld-Orn I., Savey A., Szilagyi E., Valinteliene R., Fabry J., Gastmeier P. Methicillin-resistant Staphylococcus aureus (MRSA) in Europe: which infection control measures are taken?. Infection 2010, 38:159-164.
16. Jahamy H., Ganga R., Raiy B.A., Shemes S., Nagappan V., Sharma M., Riederer K., Khatib R. Staphylococcus aureus skin/soft-tissue infections: the impact of SCCmec type and Panton-Valentine leukocidin. Scand. J. Infect. Dis. 2008, 8:1-7.
17. Johnsson D., Molling P., Strålin K., Söderquist B. Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects. Clin. Microbiol. Infect. 2004, 10:884-889.
18. Kleinbaum D., Klein M. Logistic regression: a self-learning text 2002, Springer, New York.
19. Kuehnert M., Kruszon-Moran D., Hill H.A., McQuillan G., McAllister S.K., Fosheim G., McDougal L.K., Chaitram J., Jensen B., Fridkin S.K., Killgore G., Tenover F.C. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J. Infect. Dis. 2006, 193:172-179.
20. Kuint J., Barzilai A., Regev-Yochay G., Rubinstein E., Keller N., Maayan-Metzger A. Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit. Eur. J. Pediatr. 2007, 166:319-325.
21. Kypraios T., O'Neill P.D., Huang S.S., Rifas-Shiman S.L., Cooper B.S. Assessing the role of undetected colonization and isolation precautions in reducing methicillin-resistant Staphylococcus aureus transmission in intensive care units. BMC Infect. Dis. 2010, 10:29.
22. Labandeira-Rey M., Couzon F., Boisset S., Brown E.L., Bes M., Benito Y., Barbu E.M., Vazquez V., Höök M., Etienne J., Vandenesch F., Bowden M.G. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007, 315:1130-1133.
23. Lalani T., Federspiel J., Boucher H.W., Rude T.H., Bae I.G., Rybak M.J., Tonthat G.T., Corey G.R., Stryjewski M.E., Sakoulas G., Chu V.H., Alder J., Steenbergen J.N., Luperchio S.A., Campion M., Woods C.W., Fowler V.G. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J. Clin. Microbiol. 2008, 46:2890-2896.
24. Laupland K., Ross T., Gregson D.B. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J. Infect. Dis. 2008, 198:336-343.
25. Lowy F., Aiello A., Bhat M., Johnson-Lawrence V.D., Lee M.H., Burrell E., Wright L.N., Vasquez G., Larson E.L. Staphylococcus aureus colonization and infection in New York State prisons. J. Infect. Dis. 2007, 196:911-918.
26. Moran G., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., Talan D.A. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Eng. J. Med. 2006, 355:666-674. EMERGEncy ID Net Study Group.
27. Morgan M. Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int. J. Antimicrob. Agents 2007, 30:289-296.
28. Nijssen S., Bonten J., Weinstein R.A. Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus?. Clin. Infect. Dis. 2005, 40:405-409.
29. Ruotsalainen E., Karden-Lilja M., Kuusela P., Vuopio-Varkila J., Virolainen-Julkunen A., Sarna S., Valtonen V., Järvinen A. Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics. J. Infect. 2008, 56:249-256.
30. Safdar N., Bradley E. The risk of infection after nasal colonization with Staphylococcus aureus. Am. J. Med. 2008, 121:310-315.
31. Shrestha N., Tuohy M., Padmanabhan R.A., Hall G.S., Procop G.W. Evaluation of the LightCycler Staphylococcus M GRADE kits on positive blood cultures that contained gram-positive cocci in clusters. J. Clin. Microbiol. 2005, 43:6144-6146.
32. Skiest D., Brown K., Cooper T.W., Hoffman-Roberts H., Mussa H.R., Elliott A.C. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J. Infect. 2007, 54:427-434.
33. Skiest D., Brown K., Hester J., Moore T., Crosby C., Mussa H.R., Hoffman-Roberts H., Cooper T. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med. 2006, 7:361-368.
34. Tristan A., Ferry T., Durand G., Dauwalder O., Bes M., Lina G., Vandenesch F., Etienne J. Virulence determinants in community and hospital methicillin-resistant Staphylococcus aureus. J. Hosp. Infect. 2007, 65:105-109.
35. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M.E., Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 2003, 9:978-984.
36. Vidal P., Trindade P., Garcia T.O., Pacheco R.L., Costa S.F., Reinert C., Hiramatsu K., Mamizuka E.M., Garcia C.P., Levin A.S. Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain. Infect. Control Hosp. Epidemiol. 2009, 30:139-145.
37. Voyich J., Otto M., Mathema B., Braughton K.R., Whitney A.R., Welty D., Long R.D., Dorward D.W., Gardner D.J., Lina G., Kreiswirth B.N., DeLeo F.R. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?. J. Infect. Dis. 2006, 194:1761-1770.
38. Wang J., Chen S., Wang J.T., Wu G.H., Chiang W.C., Hsueh P.R, Chen Y.C., Chang S.C. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin. Infect. Dis. 2008, 46:799-806.
39. Wang J., Wang J., Chen S.Y., Hsueh P.R., Hsueh P.R, Kung H.C., Kung Y.C., Chang S.C. Adult methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: clinical significance of non-multi-resistant antibiogram and Panton-Valentine leukocidin gene. Diagn. Microbiol. Infect. Dis. 2007, 59:365-371.
40. Ward P., Turner W. Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. Infect. Immun. 1980, 28:393-397.
41. Weber D.J., Hoffmann K.K., Rutala W.A., Pyatt DG. Control of healthcare-associated Staphylococcus aureus: survey of practices in North Carolina hospitals. Infect. Control Hosp. Epidemiol. 2009, 30:909-911.
42. Wertheim H., Vos M.C., Ott A., Voss A., Kluytmans J.A., Vandenbroucke-Grauls C.M., Meester M.H., van Keulen P.H., Verbrugh H.A. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients. Ann. Intern. Med. 2004, 140:419-425.